NANOBODY®(a registered trademark of Ablynx NV) molecules (Nbs), also referred to as
single domain-based VHHs, are antibody fragments derived from heavy-chain only IgG …

Nanobodies (Nbs) are antibody fragments derived from heavy-chain-only IgG antibodies
found in the Camelidae family as well as cartilaginous fish. Their unique structural and …

Background No agents are currently available for the treatment or reversal of liver fibrosis.
Novel antifibrotic therapies for chronic liver diseases are thus urgently needed. Connective …

Background Gastric cancer represents a highly lethal malignancy with an elevated mortality
rate among cancer patients, coupled with a suboptimal postoperative survival prognosis …

Nanobody (Nb) is derived from the variable domain of heavy-chain antibody (HCAb),
naturally displaying notable properties like nano-scale size, exceptional stability, high …

IgE-mediated allergies represent a major health problem in the modern world. Apart from
allergen-specific immunotherapy (AIT), the only disease-modifying treatment, researchers …

Nanobodies (Nbs) represent a class of single-domain antibodies with great potential
application value across diverse biotechnology fields, including therapy and diagnostics …

A total of 133 therapeutic mAbs have been approved for the European market (https://www.
pei. de/DE/arzneimittel/anti koerper/monoklonale-antikoerper/monoklonale-antikoerper …

Hedefleme amacıyla tedavilerde kullanılan geleneksel antikorlar, kanser başta olmak çeşitli
hastalıklarda önemli başarılar sağlamıştır. Ancak büyük boyutları ve buna bağlı olarak kısıtlı …

Asthma is one of the most common chronic diseases that is widespread in the world. It is an
immune-mediated inflammatory disease with intermittent and reversible narrowing of the …